Top Sell
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biogen Inc. | 51 | 2 | 1 | 0 | €181.10 | €283.73 | 56.668% |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.45 | - | - |
| Trevena Inc. | 2 | 23 | 0 | 0 | €0.15 | €6.48 | 4136.601% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.78 | €21.44 | 216.292% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.54 | - | - |
| Bluebird Bio Inc. | 7 | 6 | 0 | 0 | €0.47 | €5.47 | 1055.424% |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| Immuron | 0 | 1 | 0 | 0 | €2.12 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.20 | €7.31 | 128.307% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.55 | - | - |
| Viking Therapeutics Inc | 5 | 1 | 1 | 0 | €48.84 | €110.00 | 125.225% |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.96 | €2.00 | 108.290% |
| Intellia Therapeutics Inc | 15 | 1 | 0 | 0 | €17.79 | €60.53 | 240.236% |
| Compugen Ltd. | 3 | 2 | 0 | 0 | €1.65 | €3.66 | 121.560% |
| Bristol-Myers Squibb | 8 | 3 | 1 | 0 | €43.94 | €65.03 | 48.004% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.00 | €50.00 | 38.889% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €4.88 | €11.00 | 125.456% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 91.388% |
| Enlivex Therapeutics Ltd. | 0 | 1 | 0 | 0 | €1.09 | - | - |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.09 | €50.00 | 4499.816% |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Minerva Neurosciences Inc. | 0 | 11 | 0 | 1 | €2.36 | - | - |